The role of miR-149 was explored in glioblastoma where it was found to inhibit the expression of MMP-2, p-AKT1, proliferating cell nuclear antigen (PCNA), cyclin D1, as well as proliferation and invasion in U251 cells [95]. Here, PCNA is linked to glioblastoma.